MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
7.63
+0.12 (1.60%)
Apr 17, 2025, 4:00 PM EDT - Market closed

MBX Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22
Market Capitalization
255616--
Enterprise Value
-7339--
Last Close Price
7.6218.43--
Debt / Equity Ratio
0.000.000.000.01
Quick Ratio
23.7823.7820.6012.42
Current Ratio
24.1924.1921.2612.89
Return on Equity (ROE)
-36.71%-36.71%-53.75%-
Return on Assets (ROA)
-24.17%-24.17%-34.14%-
Return on Capital (ROIC)
-25.23%-25.23%-36.20%-
Buyback Yield / Dilution
-94470.00%-944.70%-52.73%-
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q